← Back to Search

Behavioral Intervention

Behavioral Intervention for Lung Cancer (LuCA Trial)

N/A
Waitlist Available
Led By Rebecca A Shelby, PhD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient Participants: 60 years of age or older
Patient Participants: Lung cancer diagnosis
Must not have
Visual or hearing impairment, cognitive impairment, or severe mental illness interfering with participation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 5 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to create a short assessment and behavioral intervention to help older adults with lung cancer manage their specific concerns related to aging. The study involves interviewing patients, caregivers, and healthcare providers to gather feedback

Who is the study for?
This trial is for older adults with lung cancer. It aims to help them manage symptoms and improve well-being by addressing aging-specific concerns. Participants will include patients, caregivers, and providers who can give feedback via teleconference interviews on the assessment and intervention materials.
What is being tested?
The LuCA Behavioral Intervention is being tested to see if it's helpful for older lung cancer patients in managing their symptoms related to aging. The study involves interviews to refine the program and a later phase where participants use the revised tools to check for improvements in mood and physical discomfort.
What are the potential side effects?
Since this trial focuses on behavioral interventions rather than medications, traditional side effects are not expected. However, discussing sensitive topics during interviews may cause emotional discomfort or fatigue.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 60 years old or older.
Select...
I have been diagnosed with lung cancer.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have any severe visual, hearing, cognitive impairments, or mental illnesses that would prevent me from participating.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 5 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 5 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Change in anxiety symptoms as measured by the Generalized Anxiety Disorder (GAD-7) scale
Change in depressive symptoms as measured by the Patient Health Questionnaire (PHQ-9)
Change in dyspnea as measured by the Chronic Respiratory Questionnaire (CRQ)
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Behavioral InterventionExperimental Treatment1 Intervention
Participants will engage in a 5-session protocol, to be delivered in an individual therapy setting, via telehealth or in-person. The program will integrate aspects of Cognitive Behavioral Therapy and Acceptance and Commitment Therapy.

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,445 Previous Clinical Trials
3,067,723 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,774 Previous Clinical Trials
28,185,484 Total Patients Enrolled
Rebecca A Shelby, PhDPrincipal InvestigatorDuke Psychiatry & Behavioral Sciences
3 Previous Clinical Trials
208 Total Patients Enrolled
~31 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top